takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Deborah Dunsire M.D.
Chief Executive Officer and President, EnVivo Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 168 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Dr. Deborah Dunsire, MD has been the Chief Executive Officer and President of EnVivo Pharmaceuticals, Inc. since July 11, 2013. Dr. Dunsire served as the Chief Executive Officer and President at Millennium Pharmaceuticals, Inc. from July 2005 to May 2013. Dr. Dunsire has more than 25 years of scientific, clinical, operational and commercial experience, and proven leadership in the biological and pharmaceutical industry. Dr. Dunsire served as Corporate Officer at Millennium ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Director At Large
Director, Member of Science & Technology Committee and Member of Corporate Governance & Compliance Committee
Former Chief Executive Officer, President and Director
Former Director, Chief Executive Officer of Millennium Pharmaceuticals Inc and President of Millennium Pharmaceuticals Inc
Chief Executive Officer and President
Wits Medical School
University of the Witwatersrand
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25